FROOME CLOSE
Medical Technologies
Drug Calculator
Health Economics
Drug AE
Drug Label
Drug Sync
← Main site
Health Economics — Froome Close
← Health Economics
Chronic lymphocytic leukemia
Select a treatment setting
First-line/Induction
First-line therapy
Regimens
17
With dosing
17
›
First-line therapy non-randomized or retrospective data
Regimens
15
With dosing
14
›
First-line therapy randomized data
Regimens
24
With dosing
23
›
First-line therapy, non-randomized or retrospective data
Regimens
1
With dosing
1
›
First-line therapy, randomized data
Regimens
1
With dosing
0
›
Maintenance
Consolidation and/or maintenance after first-line therapy
Regimens
5
With dosing
4
›
Consolidation and/or maintenance after subsequent lines of therapy
Regimens
10
With dosing
6
›
Relapsed/Refractory/Later-line
Relapsed or refractory non-randomized or retrospective data
Regimens
25
With dosing
24
›
Relapsed or refractory randomized data
Regimens
17
With dosing
17
›
Subsequent lines of therapy
Regimens
5
With dosing
5
›